Treatment of chronic spinal cord injury patients by autologous bone marrow stem cell-derived growth and trophic factors (safety profile and clinical results)

A. Hadjianev, V. Bussarsky, N. Mirchev, K. Romansky, M. Marinov, V. Karakostov, C. Botev, M. Mincheff, I. Tonev, V. Hrischev & I. Altankova
Background: Studies of stem cell infusion in animals and humans with different neurological disorders have shown significant promise with no significant risks to general health. Patients with traumatic spinal cord injury (SCI) may benefit from regenerative therapy by intrathecal infusion of cell derived[for full text, please go to the a.m. URL]